We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Pfizer Healthcare Ireland

9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Medical Information Website: http://www.pfizermedicalinformation.ie
Patient Information Leaflet last updated on medicines.ie: 16/03/2017
PIL Caverject 10mcg & 20mcg Powder and Solvent for Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 16/03/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Removal of one or more presentations from joint PIL
Updated on 19/01/2016 and displayed until 16/03/2017
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 27/11/2015 and displayed until 19/01/2016
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to date of revision
Updated on 28/08/2014 and displayed until 27/11/2015
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 18/08/2014 and displayed until 28/08/2014
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 23/07/2014 and displayed until 18/08/2014
Reasons for adding or updating:
  • Change to date of revision
  • Change to packaging
  • Change to further information section
  • Change of special precautions for disposal
Updated on 18/02/2014 and displayed until 23/07/2014
Reasons for adding or updating:
  • Change of licence holder
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 06/09/2013 and displayed until 18/02/2014
Reasons for adding or updating:
  • Change to further information section
Updated on 27/02/2013 and displayed until 06/09/2013
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to further information section
  • Change to date of revision
  • Change to dosage and administration
  • Change to improve clarity and readability
  • Change due to user-testing of patient information
Updated on 10/04/2012 and displayed until 27/02/2013
Reasons for adding or updating:
  • Change to storage instructions
  • Change to further information section
Updated on 20/10/2011 and displayed until 10/04/2012
Reasons for adding or updating:
  • Change to marketing authorisation holder
  • Change to date of revision
Updated on 23/09/2009 and displayed until 20/10/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 31/07/2008 and displayed until 23/09/2009
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 12/06/2006 and displayed until 31/07/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 13/03/2006 and displayed until 12/06/2006
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Alprostadil